Chi-Yi Chen
Chung Shan Medical University Hospital(TW)
Research Areas
Lung Cancer Treatments and Mutations, Heat shock proteins research, PI3K/AKT/mTOR signaling in cancer, Hippo pathway signaling and YAP/TAZ, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression(2017)49 cited
- → An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non–small cell lung cancer via persistent activation of ERK signalling(2017)38 cited